Human Genome Epidemiology Literature Finder
|
Records 1 - 16 (of 16 Records) |
| Query Trace: Oligodendroglioma and ATRX[original query] |
|---|
| ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta neuropathologica 2015 Jan 129 (1): 133-46. Reuss David E, Sahm Felix, Schrimpf Daniel, Wiestler Benedikt, Capper David, Koelsche Christian, Schweizer Leonille, Korshunov Andrey, Jones David T W, Hovestadt Volker, Mittelbronn Michel, Schittenhelm Jens, Herold-Mende Christel, Unterberg Andreas, Platten Michael, Weller Michael, Wick Wolfgang, Pfister Stefan M, von Deimling Andre |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas. Oncotarget 2015 Jul . Leeper Heather E, Caron Alissa A, Decker Paul A, Jenkins Robert B, Lachance Daniel H, Giannini Cateri |
| Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas. Histopathology 2015 May . Hewer Ekkehard, Vajtai Istvan, Dettmer Matthias S, Berezowska Sabina, Vassella Er |
| ATRX immunostaining predicts IDH and H3F3A status in gliomas. Acta neuropathologica communications 2016 4 (1): 60. Ebrahimi Azadeh, Skardelly Marco, Bonzheim Irina, Ott Ines, Mühleisen Helmut, Eckert Franziska, Tabatabai Ghazaleh, Schittenhelm Je |
| Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
| Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta neuropathologica 2017 Mar . Pekmezci Melike, Rice Terri, Molinaro Annette M, Walsh Kyle M, Decker Paul A, Hansen Helen, Sicotte Hugues, Kollmeyer Thomas M, McCoy Lucie S, Sarkar Gobinda, Perry Arie, Giannini Caterina, Tihan Tarik, Berger Mitchel S, Wiemels Joseph L, Bracci Paige M, Eckel-Passow Jeanette E, Lachance Daniel H, Clarke Jennifer, Taylor Jennie W, Luks Tracy, Wiencke John K, Jenkins Robert B, Wrensch Margaret |
| Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
| von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
| Allergy may confer better survival on patients with gliomas. Clinical neurology and neurosurgery 2019 1 177 63-67. Lehrer Steven, Rheinstein Peter H, Rosenzweig Kenneth |
| Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1. Neuro-oncology advances 0 2 (1): vdaa042. Alghamri Mahmoud S, Thalla Rohit, Avvari Ruthvik P, Dabaja Ali, Taher Ayman, Zhao Lili, Ulintz Peter J, Castro Maria G, Lowenstein Pedro |
| Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
| Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis. Scientific reports 2023 5 13 (1): 6761. Kwanghoon Lee, Seong-Ik Kim, Eric Eunshik Kim, Yu-Mi Shim, Jae-Kyung Won, Chul-Kee Park, Seung Hong Choi, Hongseok Yun, Hyunju Lee, Sung-Hye Pa |
| Clinical sequencing reveals diagnostic, therapeutic, and prognostic biomarkers for adult-type diffuse gliomas. Heliyon 2024 9 10 (18): e37712. Zhenyan Li, Zhenghao Deng, Fangkun Liu, Chuntao Li, Kui Yang, Xuan Gong, Songshan Feng, Yu Zeng, Hongshu Zhou, Fan Fan, Chengke Luo, Zhixiong Liu, Mingyu Zha |
| Molecular Pathology of Gliomas. Clinics in laboratory medicine 2024 5 44 (2): 149-159. Kristyn Galbraith, Matija Snude |
| TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study. Cancer medicine 2025 1 14 (2): e70533. Hao Xing, Delin Liu, Junlin Li, Yulu Ge, Xiaopeng Guo, Wenlin Chen, Dachun Zhao, Yixin Shi, Yilin Li, Yaning Wang, Yuekun Wang, Yu Xia, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Shanmu Jin, Tian Qu, Siying Guo, Huanzhang Li, Tianrui Yang, Kun Zhang, Yu Wang, Wenbin |
- Page last reviewed:Feb 1, 2024
- Content source: